Recently Featured
two business people discussing a partnership

GEBRO and Spektus Partner for ActraFlex Commercialization

November 5, 2026
GEBRO Holding and Spektus Pharma have established a global commercialisation partnership for ActraFlex, an extended-release pain management therapy taken twice daily. This collaboration may enhance the market presence of ActraFlex and improve access for patients in need of pain management solutions. The partnership could also provide GEBRO and Spektus with opportunities to leverage each other’s…
Scientist analyzing blood samples in a lab

Alamar and Nightingale Health Launch UK Biobank Neurodegeneration Study

November 5, 2026
Alamar Biosciences and Nightingale Health have announced the UK Biobank Proteomics for Risk Identification and Signatures of brain health in Midlife (UKB-PRISM) study, which aims to test an ultrasensitive platform for detecting scarce blood proteins that may indicate neurodegeneration. The study will analyze 80,000 blood samples, potentially identifying biomarkers years before symptoms manifest. Nightingale will…
scientist analyzing drug trial results

Servier’s $1.55 Billion Muscular Dystrophy Drug Fails Key Trial

November 4, 2026
The French pharma Servier announced that its experimental drug, sevasemten, has failed to demonstrate efficacy in slowing a rare form of muscular dystrophy during a long placebo-controlled trial. This drug was acquired in June for $1.55 billion in cash, with an additional potential $1 billion in milestones. The results from the pivotal GRAND CANYON study…
Executives discussing drug launch plans

Vertex Addresses Concerns Over Kidney Drug Launch

November 4, 2026
On a conference call, executives at Vertex Pharmaceuticals expressed confidence in the upcoming launch of their IgA nephropathy medicine. This drug is considered crucial for the company’s future by Wall Street investors. The executives aimed to calm fears surrounding the product ahead of an FDA decision. This reassurance may help stabilize investor sentiment as the…

Ongoing Cases